https://www.taxtmi.com/caselaws?id=182642 Under the Drugs and Cosmetics Act, a manufacturer is not automatically entitled to a portion of the sample or the Government Analyst's report when the sample was taken from a retailer and the statutory conditions in Section 23(4)(iii) are not met. However, Section 25(3) must be read so that its conclusive effect applies only to a person who actually receives the statutory copy and does not controvert it within time; otherwise the provision would deny a real opportunity to challenge the report. A manufacturer not served with the report may still dispute it by other evidence and may seek analysis by the Central Drugs Laboratory under Section 25(4). en-us Fri, 16 Mar 2001 00:00:00 +0530 Mon, 16 May 2016 16:01:35 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=182642 Under the Drugs and Cosmetics Act, a manufacturer is not automatically entitled to a portion of the sample or the Government Analyst's report when the sample was taken from a retailer and the statutory conditions in Section 23(4)(iii) are not met. However, Section 25(3) must be read so that its conclusive effect applies only to a person who actually receives the statutory copy and does not controvert it within time; otherwise the provision would deny a real opportunity to challenge the report. A manufacturer not served with the report may still dispute it by other evidence and may seek analysis by the Central Drugs Laboratory under Section 25(4). Case-Laws Indian Laws Fri, 16 Mar 2001 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=182642